Appetite Stimulation in Severe Dementia
Pharmacological appetite stimulants are NOT recommended for patients with severe dementia, as the evidence is very limited and potential risks outweigh uncertain benefits. 1, 2
Why Appetite Stimulants Should Be Avoided in Severe Dementia
The systematic use of appetite stimulants cannot be recommended for patients with dementia and reduced appetite due to:
- Very limited evidence from only small trials with weak methodology that did not achieve consistent effects on outcomes 1
- Unknown mechanisms of action and various potentially harmful side effects that must be considered 1
- Specific guideline recommendation that drugs to stimulate appetite are NOT recommended for persons with dementia 2
The evidence base consists primarily of:
- One small study (n=11) showing increased body weight with dronabinol but with unclear clinical significance 1
- Two studies of megestrol acetate in mixed populations (only 41% with dementia) showing inconsistent results 1
- A retrospective chart review (n=40) of dronabinol showing improved meal consumption but lacking rigorous methodology 1
What You Should Do Instead: Non-Pharmacological Approaches
Focus on comprehensive environmental and behavioral strategies that address the root causes of poor appetite rather than attempting pharmacological stimulation. 1, 2
Step 1: Identify and Address Modifiable Causes
Conduct a systematic review to eliminate treatable causes of poor appetite: 1
- Oral and dental problems: Provide adequate oral care and dental treatment 1
- Medication side effects: Review all medications for appetite-suppressing effects (opioids, sedatives, digoxin, metformin, antibiotics, NSAIDs) 1
- Cholinesterase inhibitors: Consider that dementia medications themselves may cause weight loss in vulnerable patients 1
- Pain and acute illness: Ensure adequate medical treatment 1
- Dietary restrictions: Remove any unnecessary dietary restrictions that may limit intake 1
Step 2: Optimize the Eating Environment
Create a social, supportive dining experience: 1, 2
- Shared meals: Encourage eating with others (family, staff, or other residents) as this significantly improves intake and quality of life 1, 3
- Consistent caregivers: Assign the same staff members to assist with meals when possible 2
- Adequate time: Increase time spent by nursing staff during feeding assistance 1, 2
- Emotional support: Provide verbal prompting, encouragement, and specific behavioral communication strategies 1, 2
Step 3: Modify Food and Meal Structure
Adapt meals to individual preferences and abilities: 1, 2
- Energy-dense meals: Provide calorie-rich foods to meet nutritional needs without increasing volume 1, 2
- Texture modification: Offer texture-modified foods for patients with dysphagia 1
- Finger foods: Provide foods that can be eaten without utensils for patients with declining motor skills 2
- Small, frequent meals: Offer snacks between meals and make them available throughout the day 2
- Preferred foods: Honor individual food preferences and cultural traditions 1
Step 4: Consider Oral Nutritional Supplements
Provide oral nutritional supplements (ONS) when dietary intake falls to 50-75% of usual intake. 2
- Use protein-enriched foods and drinks to improve protein intake 2
- Offer supplements between meals rather than replacing meals 2
The One Exception: Concurrent Depression
If the patient has a concomitant depressive syndrome requiring pharmacological treatment, mirtazapine (7.5-15 mg at bedtime) might be considered as it has appetite-stimulating properties. 1, 4
This represents the only scenario where pharmacological intervention for appetite may be appropriate in dementia, as you are treating depression rather than attempting isolated appetite stimulation. 1, 4
Critical Caveats for Severe Dementia
- In severe dementia specifically, formal standardized nutritional assessments can be burdensome and cause more harm than good 1
- Focus should shift to informal identification of individual needs and problems with the goal of enabling optimal personalized palliative care 1
- Interventions should only be taken as long as clinically appropriate - if a potentially helpful intervention is associated with appreciable burden and risks (such as complex treatments in frail patients with severe dementia), potential benefits must be weighed against risks 1
What NOT to Do
Avoid these common pitfalls: 4, 2, 5
- Do not use appetite stimulants if the patient has dementia with no evidence of depression 4
- Do not use megestrol acetate systematically in dementia patients despite its effectiveness in cancer-related cachexia 2
- Do not use dronabinol, as cannabinoid administration in elderly patients may induce delirium 5
- Do not continue interventions that increase burden without clear benefit to quality of life 1